Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Thrombin-thrombomodulin-protein C complex is a vital regulatory assembly located on the vascular endothelial surface that serves as a primary switch for the coagulation cascade (PMID: 12912744). In this complex, thrombin binds to the membrane-bound receptor thrombomodulin, which undergoes a conformational change that eliminates its procoagulant activity toward fibrinogen and platelets while simultaneously increasing its efficiency in activating protein C by approximately 1,000-fold (PMID: 15153605). Once activated, protein C (APC) acts as a potent anticoagulant by proteolytically inactivating factors Va and VIIIa, thereby limiting further thrombin generation. Beyond its role in hemostasis, the complex and its product APC mediate significant anti-inflammatory and cytoprotective effects through signaling pathways involving protease-activated receptor 1 (PAR-1) and the endothelial protein C receptor (EPCR) (PMID: 17311987). Dysfunction or deficiency in the components of this complex is strongly associated with clinical conditions such as deep vein thrombosis, pulmonary embolism, and severe sepsis. Therapeutic interventions often involve the administration of recombinant soluble thrombomodulin or protein C concentrates to restore the anticoagulant and protective balance in patients with thrombotic or inflammatory disorders (PMID: 22133541).
The complex functions by shifting thrombin's substrate specificity from procoagulant substrates like fibrinogen to the anticoagulant zymogen protein C; thrombomodulin binds thrombin, and this binary complex then recruits and activates protein C into activated protein C (APC), which subsequently degrades factors Va and VIIIa to inhibit further thrombin generation (PMID: 12912744, 15153605).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thrombin-thrombomodulin-protein C complex (T-TM-PC).